The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.36

Today's change+0.04 +3.03%
Updated June 27 1:09 PM EDT. Delayed by at least 15 minutes.
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $1.36

Today's change+0.04 +3.03%
Updated June 27 1:09 PM EDT. Delayed by at least 15 minutes.

Infinity Pharmaceuticals Inc up sharply

Infinity Pharmaceuticals Inc is up sharply today, rallying (U.S.)$0.04 or 3.03% to (U.S.)$1.36. Over the last five days, shares have lost 2.16% and are down 82.68% for the last year to date. This security has underperformed the S&P 500 by 82.65% during the last year.

Key company metrics

  • Open(U.S.) $1.32
  • Previous close(U.S.) $1.32
  • High(U.S.) $1.39
  • Low(U.S.) $1.27
  • Bid / Ask(U.S.) $1.36 / (U.S.) $1.37
  • YTD % change-82.68%
  • Volume759,658
  • Average volume (10-day)4,995,980
  • Average volume (1-month)1,920,987
  • Average volume (3-month)1,033,620
  • 52-week range(U.S.) $1.24 to (U.S.) $11.13
  • Beta1.69
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.52
Updated June 27 1:09 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.52%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue99915
Total other revenue--------
Total revenue99915
Gross profit--------
Total cost of revenue--------
Total operating expense50484743
Selling / general / administrative119109
Research & development39393834
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-41-3943-39
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-41-3943-38
Income after tax-41-3943-38
Income tax, total--00--
Net income-41-3943-38
Total adjustments to net income-----1--
Net income before extra. items-41-3943-38
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-41-3942-38
Inc. avail. to common incl. extra. items-41-3942-38
Diluted net income-41-3942-38
Dilution adjustment----0--
Diluted weighted average shares49495049
Diluted EPS excluding extraordinary itemsvalue per share-0.82-0.800.84-0.78
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.82-0.800.84-0.78